Trials / Terminated
TerminatedNCT03343756
HepaStem Long-Term Safety Registry
HepaStem Long-Term Safety Registry - Registry for Patients Who Have Been Administered HepaStem
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 44 (actual)
- Sponsor
- Cellaion SA · Industry
- Sex
- All
- Age
- 5 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
All patients having received at least one infusion of the Investigational Medicinal Product (IMP) HepaStem HHALPC during a previous interventional clinical study conducted by Promethera Biosciences
Conditions
Timeline
- Start date
- 2018-04-04
- Primary completion
- 2024-05-23
- Completion
- 2024-05-23
- First posted
- 2017-11-17
- Last updated
- 2024-05-29
Locations
29 sites across 5 countries: Belgium, Bulgaria, France, Poland, Spain
Source: ClinicalTrials.gov record NCT03343756. Inclusion in this directory is not an endorsement.